Characteristics of subtype III-A CRISPR-Cas system in Mycobacterium tuberculosis: An overview

被引：4
|
作者：
Hamdi, Insaf [1 ]
Boni, Funmilayo [1 ]
Shen, Qinglei [1 ]
Moukendza, Liadrine [1 ]
Peibo, Li [2 ]
Jianping, Xie [1 ,2 ]
机构：
[1] Southwest Univ, Inst Modern Biopharmaceut,Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Ecoenvironm Three Gorges Reservoir Reg,Min, Chongqing 400715, Peoples R China
[2] Southwest Univ, Publ Hlth Hosp, Chongqing Publ Hlth Med Ctr, Chongqing 400030, Peoples R China
来源：
INFECTION GENETICS AND EVOLUTION | 2023年 / 112卷
关键词：
Mycobacterium tuberculosis; CRISPR-Cas III-A; Reverse transcriptase (RT); Housekeeping nuclease-anti-CRISPR; CRISPRi; COMPLEX; RNA; BACTERIA; CLASSIFICATION; MECHANISMS; KNOCKDOWN; INSIGHTS; ROLES;
D O I：
10.1016/j.meegid.2023.105445
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
CRISPR-Cas systems are the only RNA- guided adaptive immunity pathways that trigger the detection and destruction of invasive phages and plasmids in bacteria and archaea. Due to its prevalence and mystery, the Class 1 CRISPR-Cas system has lately been the subject of several studies. This review highlights the specificity of CRISPR-Cas system III-A in Mycobacterium tuberculosis, the tuberculosis-causing pathogen, for over twenty years. We discuss the difference between the several subtypes of Type III and their defence mechanisms. The antiCRISPRs (Acrs) recently described, the critical role of Reverse transcriptase (RT) and housekeeping nuclease for type III CRISPR-Cas systems, and the use of this cutting-edge technology, its impact on the search for novel anti-tuberculosis drugs.
引用
收藏
页数：11
相关论文
共 50 条
  • [1] The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress
    Yang, Fan
    Xu, Lingqing
    Liang, Lujie
    Liang, Wanfei
    Li, Jiachen
    Lin, Daixi
    Dai, Min
    Zhou, Dianrong
    Li, Yaxin
    Chen, Yong
    Zhao, Hui
    Tian, Guo-bao
    Feng, Siyuan
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [2] EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis
    Shi, Mingmin
    Zhang, Hongtai
    Fleming, Joy
    Wei, Wenjing
    Chen, Hong
    Dai, Xiaowei
    Liu, Yi
    Li, Chuanyou
    Ran, Fanlei
    Wu, Zhilong
    Wang, Yaguo
    Zhang, Xilin
    Zhang, Huizhi
    Bi, Lijun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [3] Unique properties of spacer acquisition by the type III-A CRISPR-Cas system
    Zhang, Xinfu
    Garrett, Sandra
    Graveley, Brenton R.
    Terns, Michael P.
    NUCLEIC ACIDS RESEARCH, 2022, 50 (03) : 1562 - 1582
  • [4] Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
    Tamulaitis, Gintautas
    Kazlauskiene, Migle
    Manakova, Elena
    Venclovas, Ceslovas
    Nwokeoji, Alison O.
    Dickman, Mark J.
    Horvath, Philippe
    Siksnys, Virginijus
    MOLECULAR CELL, 2014, 56 (04) : 506 - 517
  • [5] Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System
    Hatoum-Aslan, Asma
    Maniv, Inbal
    Samai, Poulami
    Marraffini, Luciano A.
    JOURNAL OF BACTERIOLOGY, 2014, 196 (02) : 310 - 317
  • [6] Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features
    Wei, Wenjing
    Zhang, Shuai
    Fleming, Joy
    Chen, Ying
    Li, Zihui
    Fan, Shanghua
    Liu, Yi
    Wang, Wei
    Wang, Ting
    Liu, Ying
    Ren, Baiguang
    Wang, Ming
    Jiao, Jianjian
    Chen, Yuanyuan
    Zhou, Ying
    Zhou, Yafeng
    Gu, Shoujin
    Zhang, Xiaoli
    Wan, Li
    Chen, Tao
    Zhou, Lin
    Chen, Yong
    Zhang, Xian-En
    Li, Chuanyou
    Zhang, Hongtai
    Bi, Lijun
    FASEB JOURNAL, 2019, 33 (01): : 1496 - 1509
  • [7] Lactococcus lactis type III-A CRISPR-Cas system cleaves bacteriophage RNA
    Millen, Anne M.
    Samson, Julie E.
    Tremblay, Denise M.
    Magadan, Alfonso H.
    Rousseau, Genevieve M.
    Moineau, Sylvain
    Romero, Dennis A.
    RNA BIOLOGY, 2019, 16 (04) : 461 - 468
  • [8] Programmable type III-A CRISPR-Cas DNA targeting modules
    Ichikawa, H. Travis
    Cooper, John C.
    Lo, Leja
    Potter, Jason
    Terns, Rebecca M.
    Terns, Michael P.
    PLOS ONE, 2017, 12 (04):
  • [9] Specialized Weaponry: How a Type III-A CRISPR-Cas System Excels at Combating Phages
    Niewoehner, Ole
    Jinek, Martin
    CELL HOST & MICROBE, 2017, 22 (03) : 258 - 259
  • [10] A type III-A CRISPR-Cas System employs degradosome necleases to ensure robust immunity
    Chou-Zheng, Lucy
    Hatoum-Aslan, Asma
    ELIFE, 2019, 8
12345